| Nuclear receptors in liver fibrosis P Königshofer, K Brusilovskaya, O Petrenko, BS Hofer, P Schwabl, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1867 (12), 166235, 2021 | 32 | 2021 |
| Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies P Königshofer, BS Hofer, K Brusilovskaya, B Simbrunner, O Petrenko, ... Hepatology, 2021 | 31 | 2021 |
| Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis L Burghart, E Halilbasic, P Schwabl, B Simbrunner, AF Stättermayer, ... Journal of Gastroenterology 57 (2), 99-110, 2022 | 19 | 2022 |
| Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis J Reiniš, O Petrenko, B Simbrunner, BS Hofer, F Schepis, M Scoppettuolo, ... Journal of Hepatology 78 (2), 390-400, 2023 | 17 | 2023 |
| Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertension P Schwabl, BA Seeland, F Riedl, TL Schubert, P Königshofer, ... Advances in Medical Sciences 67 (1), 154-162, 2022 | 11 | 2022 |
| Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis BS Hofer, L Burghart, E Halilbasic, B Simbrunner, O Petrenko, ... Alimentary Pharmacology & Therapeutics 59 (8), 962-972, 2024 | 4 | 2024 |
| Portal hypertension and its prognostic implications in patients with Wilson's disease L Burghart, P Ferenci, O Petrenko, M Mandorfer, M Schwarz, ... Alimentary Pharmacology & Therapeutics, 2024 | 2 | 2024 |
| Transcriptomic signatures of progressive and regressive liver fibrosis and portal hypertension O Petrenko, P Königshofer, K Brusilovskaya, BS Hofer, K Bareiner, ... Iscience 27 (3), 2024 | 2 | 2024 |
| FXR-FGF19 signaling in the gut–liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence B Simbrunner, BS Hofer, P Schwabl, K Zinober, O Petrenko, C Fuchs, ... Hepatology International, 1-14, 2024 | 2 | 2024 |
| Тенденції застосування допоміжних репродуктивних технологій в Україні ВО Ситнікова, ОО Петренко Одеський медичний журнал, 67-69, 2017 | 2 | 2017 |
| Metabolomic profiles differentiate between porto-sinusoidal vascular disorder, liver cirrhosis, and healthy individuals G Semmler, O Petrenko, JJ Lozano, S Shalaby, JI Sánchez-Avila, ... JHEP Reports, 101208, 2024 | | 2024 |
| SAT-161 Inhibition of bile acid conjugation improves DDC-induced cholestatic liver injury in mice with a humanized bile acid pool C Fuchs, O Petrenko, V Mlitz, H Scharnagl, T Stojakovic, T Reiberger, ... Journal of Hepatology 80, S296, 2024 | | 2024 |
| WED-122-YI The soluble guanylate cyclase pathway is dysregulated in rodent models of cirrhosis and portal hypertension T Sorz-Nechay, K Brusilovskaya, P Konigshofer, B Hofer, O Petrenko, ... Journal of Hepatology 80, S197, 2024 | | 2024 |
| WED-125 Differential regulation of soluble guanylate cyclase signaling during liver fibrosis regression T Sorz-Nechay, K Brusilovskaya, P Königshofer, B Hofer, O Petrenko, ... Journal of Hepatology 80, S198, 2024 | | 2024 |
| WED-089-YI Characterising the hemodynamic and pro-inflammatory profile of a CCl4/LPS-induced acute-on-chronic liver failure (ACLF) rat model V Taru, T Sorz-Nechay, B Hofer, O Petrenko, P Königshofer, K Bonitz, ... Journal of Hepatology 80, S186, 2024 | | 2024 |
| Metabolomische Profile zur Differenzierung von porto-sinusoidaler Gefäßerkrankung der Leber und Leberzirrhose L Balcar, G Semmler, O Petrenko, JJ Lozano, S Shalaby, JI Sanchez-Avila, ... Zeitschrift für Gastroenterologie 62 (05), P41, 2024 | | 2024 |
| Recompensation in PBC is good. But is it good enough? Authors' reply BS Hofer, L Burghart, E Halilbasic, B Simbrunner, O Petrenko, ... Alimentary pharmacology & therapeutics 59 (9), 1146-1147, 2024 | | 2024 |
| The resilience of Ukrainian scientists O Piven, V Pokrytiuk, N Kasianchuk, B Ostash, S Dekina, R Panchuk, ... Cell Systems 15 (4), 298-304, 2024 | | 2024 |
| FXR‑FGF19 signaling in the gut–liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence O Petrenko, C Fuchs, G Semmler, R Marculescu, M Mandorfer, C Datz, ... | | 2024 |
| DECIPHERING OF THE HEPATIC SINGLE-CELL INTERACTOME IN PRIMARY SCLEROSING CHOLANGITIS O Petrenko, C Mangana, T Sorz, BS Hofer, B Simbrunner, K Zinober, ... HEPATOLOGY 78, S2044-S2046, 2023 | | 2023 |
